Orthopediatrics (KIDS) Cash from Investing Activities (2016 - 2026)
Orthopediatrics' (KIDS) quarterly Cash from Investing Activities came in at -$3.8 million in Q1 2026, up 36.75% year-on-year from -$2.8 million in Q1 2025, and up 47.83% on a QoQ basis from -$7.3 million in Q4 2025.
Orthopediatrics (KIDS) Cash from Investing Activities (2016 - 2026) Analysis & Trends
Orthopediatrics (KIDS) has 11 years of Cash from Investing Activities data on file, last reported at -$3.8 million in Q1 2026.
- On a quarterly basis, Cash from Investing Activities rose 36.75% year-over-year to -$3.8 million in Q1 2026; TTM through Mar 2026 was -$41.4 million, a 167.8% decrease from a year earlier, with the FY2025 full-year figure at -$43.6 million, down 231.48% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$3.8 million, up from -$7.3 million in the prior quarter.
- Over the last five years, Cash from Investing Activities for KIDS reached as high as $32.3 million in Q1 2023 and fell as low as -$103.9 million in Q3 2022.
- Historically, Cash from Investing Activities has averaged -$7.8 million across 5 years, with a median of -$3.7 million in 2024.
- Across the five-year window, Cash from Investing Activities surged 355.09% in 2022 and tumbled 3351.33% in 2023, its largest moves.
- Year by year, Cash from Investing Activities stood at -$23.2 million in 2022, then surged by 177.16% to $17.9 million in 2023, then plunged by 113.46% to -$2.4 million in 2024, then plunged by 200.95% to -$7.3 million in 2025, then soared by 47.83% to -$3.8 million in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were -$3.8 million in Q1 2026, -$7.3 million in Q4 2025, and -$26.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -298.50 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -2.50 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -475.32 Mn |
| 10 | Orthopediatrics | 468.25 Mn | 454.01 Mn | 43.39 Mn | -3.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.79 Mn |
| Mar 31, 2026 | -3.79 Mn |
| Dec 31, 2025 | -7.26 Mn |
| Dec 31, 2025 | -7.26 Mn |
| Sep 30, 2025 | -26.84 Mn |
| Sep 30, 2025 | -26.84 Mn |
| Jun 30, 2025 | -3.55 Mn |
| Jun 30, 2025 | -3.55 Mn |
| Mar 31, 2025 | -5.99 Mn |
| Mar 31, 2025 | -5.99 Mn |
| Dec 31, 2024 | -2.41 Mn |
| Dec 31, 2024 | -2.41 Mn |
| Sep 30, 2024 | -26.77 Mn |
| Sep 30, 2024 | -26.77 Mn |
| Jun 30, 2024 | 19.70 Mn |
| Jun 30, 2024 | 19.70 Mn |
| Mar 31, 2024 | -3.68 Mn |
| Mar 31, 2024 | -3.68 Mn |
| Dec 31, 2023 | 17.92 Mn |
| Dec 31, 2023 | 17.92 Mn |